OIF
- Product code
- OIF
- Device name
- Tyrosine Phosphatase (Ia-2) Autoantibody Assay
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.5660
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (all years, FDA)
- 3 (all years; only the last 3 years are listed here)
FDA classification definition
The device is used for the semi-quantitative determination of autoantibodies against tyrosine phosphatase (IA-2) in human serum as an aid in the diagnosis of Type 1 diabetes mellitus (autoimmune mediated diabetes).
Official FDA classification page: OIF
Classification and pathway per current FDA publications. Data from openFDA (CC0).